Exciting Areas Of Innovation For Cell Therapies

From cell therapies to treat solid tumors to a growing number of allogeneic cell therapies coming through the clinical pipeline, there is plenty to be excited about in the cell therapy space. In this segment from “Executive Roundtable: Cell Therapy Predictions For 2025 And Beyond,” CEO, co-founder, and president of Ossium Health, Kevin Caldwell; CSO of FibroBiologics, Hamid Khoja, Ph.D.; and president and acting CEO of Triumvira Immunologics, Rob Williamson, discuss promising innovations in the field and share what data and approvals they look forward to seeing in the coming years.